Forensic toxicology relies on spectral libraries such as those from the National Institute of Standards and Technology (NIST) and the Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG). These resources support confident identification when reference spectra are available. When a compound is absent, however, identification becomes significantly more complex.
Novel psychoactive substances (NPS) continue to emerge at a pace that exceeds database updates. Small structural modifications generate new analogues that evade existing entries while retaining similar pharmacological activity.
In practice, analysts encounter high-quality spectra with no corresponding match. Interpretation then depends on fragmented knowledge, complementary data, or external intelligence. Each step increases analysis time and introduces uncertainty.
The impact on laboratory workflows is clear:
- Extended turnaround times for casework
- Reduced confidence in compound assignment
- Greater scrutiny in legal contexts
This limitation highlights the need for approaches that extend beyond traditional spectral matching.
How Do 1D-CNNs Analyze Mass Spectrometry Data?
A one-dimensional convolutional neural network (1D-CNN) approaches mass spectrometry data as a structured analytical signal rather than a database query.
Each spectrum is represented as a vector of intensity values indexed by mass-to-charge ratio (m/z). This format retains both ion positions and relative abundances, which together reflect the underlying molecular structure.
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
Convolutional filters move across the spectrum to extract localized features. These include:
- Fragment ion clusters associated with specific substructures
- Intensity relationships between adjacent peaks
- Recurring spectral motifs linked to functional groups
The model builds hierarchical feature representations. Initial layers capture simple peak relationships, while deeper layers integrate these into more complex chemical signatures.
This data-driven approach removes the need for manual feature selection. The model learns directly from raw gas chromatography–mass spectrometry (GC-MS) and liquid chromatography–mass spectrometry (LC-MS) data, enabling detection of subtle and reproducible fragmentation patterns.
Why 1D-CNNs Extend Beyond Traditional Spectral Matching
Conventional library matching depends on spectral similarity to known compounds. When no reference exists, identification cannot proceed.
A one-dimensional convolutional neural network (1D-CNN) reframes the task. Instead of identifying a specific compound, it classifies spectra based on shared fragmentation behavior.
The model evaluates how closely an unknown spectrum aligns with learned chemical patterns. It assigns probabilities across pharmacological classes such as:
- Synthetic opioids
- Cathinones
- Synthetic cannabinoids
- Amphetamine-type stimulants
This probabilistic output provides meaningful context even in the absence of a direct match. Analysts gain insight into the likely compound class, which supports prioritization and follow-up analysis.
In this way, 1D-CNNs address the practical challenge of unknown compounds by enabling informed interpretation rather than binary identification.
How Explainable AI Supports Court Admissibility (SHAP and Rule 702)
Analytical performance alone does not ensure adoption in forensic settings. Methods must also meet requirements for transparency and scientific validity.
SHapley Additive exPlanations (SHAP) values provide a mechanism to interpret model predictions. They quantify the contribution of individual m/z regions to the final classification.
In mass spectrometry applications, SHAP outputs often align with chemically relevant fragment ions. This alignment allows analysts to connect model predictions with established fragmentation pathways.
As a result, analysts can:
- Identify spectral regions that influence classification
- Relate these regions to known chemical behavior
- Communicate findings in a clear and defensible manner
This level of interpretability supports alignment with Daubert criteria and Rule 702. It strengthens confidence in the use of AI-assisted methods within forensic workflows.
What Are the Benefits of AI-Augmented Toxicology Workflows?
One-dimensional convolutional neural network (1D-CNN) models complement existing spectral libraries by extending analytical coverage.
Key benefits include:
- Faster classification of unknown novel psychoactive substances (NPS)
- Reduced reliance on reference spectra
- Improved triage in high-throughput screening environments
- Increased adaptability to emerging drug trends
These advantages translate into measurable improvements in efficiency and analytical confidence, particularly in workflows that routinely encounter unknown compounds.
The Bottom Line
The continued evolution of novel psychoactive substances (NPS) challenges the limits of traditional identification strategies. Static spectral libraries alone cannot keep pace with emerging compounds.
Artificial intelligence (AI)-driven approaches offer a complementary solution. One-dimensional convolutional neural networks (1D-CNNs) enable the classification of unknown spectra based on learned chemical patterns.
For forensic laboratories, integrating these models into mass spectrometry workflows supports faster decision-making, improved confidence, and greater robustness when addressing unknown substances.
